Global Anti-tumor Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Anti-tumor Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc.

United States is the largest market, followed by Japan, and Europe.

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.

This report studies the global Anti-tumor Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-tumor Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-tumor Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-tumor Drug total market, 2019-2030, (USD Million)
Global Anti-tumor Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Anti-tumor Drug total market, key domestic companies and share, (USD Million)
Global Anti-tumor Drug revenue by player and market share 2019-2024, (USD Million)
Global Anti-tumor Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global Anti-tumor Drug total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Anti-tumor Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda and Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-tumor Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-tumor Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-tumor Drug Market, Segmentation by Type
    Cytotoxic Drugs
    Non-cytotoxic Drugs

Global Anti-tumor Drug Market, Segmentation by Application
    Alkylating Agents
    Anti-Metabolism Drugs
    Platinum Antineoplastic Agents
    Anthracycline Antitumor Drugs
    Microtubule Stabilizer
    Endocrine Therapy Drugs
    Immunotherapy Drugs
    Gene Therapy Drugs
    Targeted Antineoplastic Drugs

Companies Profiled:
    Roche
    Novartis
    Celgene
    Bristol-Myers Squibb
    Amgen
    Johnson & Johnson
    Pfizer
    Takeda
    Eli Lilly
    AstraZeneca
    Astellas
    Merck & Co
    Sanofi
    Bayer
    Biogen Idec
    Eisai
    Teva
    Otsuka

Key Questions Answered
1. How big is the global Anti-tumor Drug market?
2. What is the demand of the global Anti-tumor Drug market?
3. What is the year over year growth of the global Anti-tumor Drug market?
4. What is the total value of the global Anti-tumor Drug market?
5. Who are the major players in the global Anti-tumor Drug market?

Table of Contents

1 Supply Summary
    1.1 Anti-tumor Drug Introduction
    1.2 World Anti-tumor Drug Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Anti-tumor Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Anti-tumor Drug Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Anti-tumor Drug Market Size (2019-2030)
        1.3.3 China Anti-tumor Drug Market Size (2019-2030)
        1.3.4 Europe Anti-tumor Drug Market Size (2019-2030)
        1.3.5 Japan Anti-tumor Drug Market Size (2019-2030)
        1.3.6 South Korea Anti-tumor Drug Market Size (2019-2030)
        1.3.7 ASEAN Anti-tumor Drug Market Size (2019-2030)
        1.3.8 India Anti-tumor Drug Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-tumor Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-tumor Drug Major Market Trends

2 Demand Summary
    2.1 World Anti-tumor Drug Consumption Value (2019-2030)
    2.2 World Anti-tumor Drug Consumption Value by Region
        2.2.1 World Anti-tumor Drug Consumption Value by Region (2019-2024)
        2.2.2 World Anti-tumor Drug Consumption Value Forecast by Region (2025-2030)
    2.3 United States Anti-tumor Drug Consumption Value (2019-2030)
    2.4 China Anti-tumor Drug Consumption Value (2019-2030)
    2.5 Europe Anti-tumor Drug Consumption Value (2019-2030)
    2.6 Japan Anti-tumor Drug Consumption Value (2019-2030)
    2.7 South Korea Anti-tumor Drug Consumption Value (2019-2030)
    2.8 ASEAN Anti-tumor Drug Consumption Value (2019-2030)
    2.9 India Anti-tumor Drug Consumption Value (2019-2030)

3 World Anti-tumor Drug Companies Competitive Analysis
    3.1 World Anti-tumor Drug Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Anti-tumor Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Anti-tumor Drug in 2023
        3.2.3 Global Concentration Ratios (CR8) for Anti-tumor Drug in 2023
    3.3 Anti-tumor Drug Company Evaluation Quadrant
    3.4 Anti-tumor Drug Market: Overall Company Footprint Analysis
        3.4.1 Anti-tumor Drug Market: Region Footprint
        3.4.2 Anti-tumor Drug Market: Company Product Type Footprint
        3.4.3 Anti-tumor Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Anti-tumor Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Anti-tumor Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Anti-tumor Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Anti-tumor Drug Consumption Value Comparison
        4.2.1 United States VS China: Anti-tumor Drug Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-tumor Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Anti-tumor Drug Companies and Market Share, 2019-2024
        4.3.1 United States Based Anti-tumor Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Anti-tumor Drug Revenue, (2019-2024)
    4.4 China Based Companies Anti-tumor Drug Revenue and Market Share, 2019-2024
        4.4.1 China Based Anti-tumor Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Anti-tumor Drug Revenue, (2019-2024)
    4.5 Rest of World Based Anti-tumor Drug Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Anti-tumor Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Anti-tumor Drug Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-tumor Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Cytotoxic Drugs
        5.2.2 Non-cytotoxic Drugs
    5.3 Market Segment by Type
        5.3.1 World Anti-tumor Drug Market Size by Type (2019-2024)
        5.3.2 World Anti-tumor Drug Market Size by Type (2025-2030)
        5.3.3 World Anti-tumor Drug Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-tumor Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Alkylating Agents
        6.2.2 Anti-Metabolism Drugs
        6.2.3 Platinum Antineoplastic Agents
        6.2.4 Anthracycline Antitumor Drugs
        6.2.5 Anthracycline Antitumor Drugs
        6.2.6 Endocrine Therapy Drugs
        6.2.7 Immunotherapy Drugs
        6.2.8 Gene Therapy Drugs
        6.2.9 Targeted Antineoplastic Drugs
    6.3 Market Segment by Application
        6.3.1 World Anti-tumor Drug Market Size by Application (2019-2024)
        6.3.2 World Anti-tumor Drug Market Size by Application (2025-2030)
        6.3.3 World Anti-tumor Drug Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Anti-tumor Drug Product and Services
        7.1.4 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Anti-tumor Drug Product and Services
        7.2.4 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Celgene
        7.3.1 Celgene Details
        7.3.2 Celgene Major Business
        7.3.3 Celgene Anti-tumor Drug Product and Services
        7.3.4 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Celgene Recent Developments/Updates
        7.3.6 Celgene Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Details
        7.4.2 Bristol-Myers Squibb Major Business
        7.4.3 Bristol-Myers Squibb Anti-tumor Drug Product and Services
        7.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Bristol-Myers Squibb Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.5 Amgen
        7.5.1 Amgen Details
        7.5.2 Amgen Major Business
        7.5.3 Amgen Anti-tumor Drug Product and Services
        7.5.4 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Amgen Recent Developments/Updates
        7.5.6 Amgen Competitive Strengths & Weaknesses
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Details
        7.6.2 Johnson & Johnson Major Business
        7.6.3 Johnson & Johnson Anti-tumor Drug Product and Services
        7.6.4 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Johnson & Johnson Recent Developments/Updates
        7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Anti-tumor Drug Product and Services
        7.7.4 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Takeda
        7.8.1 Takeda Details
        7.8.2 Takeda Major Business
        7.8.3 Takeda Anti-tumor Drug Product and Services
        7.8.4 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Takeda Recent Developments/Updates
        7.8.6 Takeda Competitive Strengths & Weaknesses
    7.9 Eli Lilly
        7.9.1 Eli Lilly Details
        7.9.2 Eli Lilly Major Business
        7.9.3 Eli Lilly Anti-tumor Drug Product and Services
        7.9.4 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Eli Lilly Recent Developments/Updates
        7.9.6 Eli Lilly Competitive Strengths & Weaknesses
    7.10 AstraZeneca
        7.10.1 AstraZeneca Details
        7.10.2 AstraZeneca Major Business
        7.10.3 AstraZeneca Anti-tumor Drug Product and Services
        7.10.4 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 AstraZeneca Recent Developments/Updates
        7.10.6 AstraZeneca Competitive Strengths & Weaknesses
    7.11 Astellas
        7.11.1 Astellas Details
        7.11.2 Astellas Major Business
        7.11.3 Astellas Anti-tumor Drug Product and Services
        7.11.4 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Astellas Recent Developments/Updates
        7.11.6 Astellas Competitive Strengths & Weaknesses
    7.12 Merck & Co
        7.12.1 Merck & Co Details
        7.12.2 Merck & Co Major Business
        7.12.3 Merck & Co Anti-tumor Drug Product and Services
        7.12.4 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Merck & Co Recent Developments/Updates
        7.12.6 Merck & Co Competitive Strengths & Weaknesses
    7.13 Sanofi
        7.13.1 Sanofi Details
        7.13.2 Sanofi Major Business
        7.13.3 Sanofi Anti-tumor Drug Product and Services
        7.13.4 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Sanofi Recent Developments/Updates
        7.13.6 Sanofi Competitive Strengths & Weaknesses
    7.14 Bayer
        7.14.1 Bayer Details
        7.14.2 Bayer Major Business
        7.14.3 Bayer Anti-tumor Drug Product and Services
        7.14.4 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Bayer Recent Developments/Updates
        7.14.6 Bayer Competitive Strengths & Weaknesses
    7.15 Biogen Idec
        7.15.1 Biogen Idec Details
        7.15.2 Biogen Idec Major Business
        7.15.3 Biogen Idec Anti-tumor Drug Product and Services
        7.15.4 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Biogen Idec Recent Developments/Updates
        7.15.6 Biogen Idec Competitive Strengths & Weaknesses
    7.16 Eisai
        7.16.1 Eisai Details
        7.16.2 Eisai Major Business
        7.16.3 Eisai Anti-tumor Drug Product and Services
        7.16.4 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Eisai Recent Developments/Updates
        7.16.6 Eisai Competitive Strengths & Weaknesses
    7.17 Teva
        7.17.1 Teva Details
        7.17.2 Teva Major Business
        7.17.3 Teva Anti-tumor Drug Product and Services
        7.17.4 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Teva Recent Developments/Updates
        7.17.6 Teva Competitive Strengths & Weaknesses
    7.18 Otsuka
        7.18.1 Otsuka Details
        7.18.2 Otsuka Major Business
        7.18.3 Otsuka Anti-tumor Drug Product and Services
        7.18.4 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Otsuka Recent Developments/Updates
        7.18.6 Otsuka Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-tumor Drug Industry Chain
    8.2 Anti-tumor Drug Upstream Analysis
    8.3 Anti-tumor Drug Midstream Analysis
    8.4 Anti-tumor Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Anti-tumor Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Anti-tumor Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Anti-tumor Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Anti-tumor Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Anti-tumor Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Anti-tumor Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Anti-tumor Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Anti-tumor Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Anti-tumor Drug Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Anti-tumor Drug Players in 2023
    Table 12. World Anti-tumor Drug Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Anti-tumor Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Anti-tumor Drug Player
    Table 15. Anti-tumor Drug Market: Company Product Type Footprint
    Table 16. Anti-tumor Drug Market: Company Product Application Footprint
    Table 17. Anti-tumor Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Anti-tumor Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Anti-tumor Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Anti-tumor Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Anti-tumor Drug Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Anti-tumor Drug Revenue Market Share (2019-2024)
    Table 23. China Based Anti-tumor Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Anti-tumor Drug Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Anti-tumor Drug Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Anti-tumor Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Anti-tumor Drug Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Anti-tumor Drug Revenue Market Share (2019-2024)
    Table 29. World Anti-tumor Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Anti-tumor Drug Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Anti-tumor Drug Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Anti-tumor Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Anti-tumor Drug Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Anti-tumor Drug Market Size by Application (2025-2030) & (USD Million)
    Table 35. Roche Basic Information, Area Served and Competitors
    Table 36. Roche Major Business
    Table 37. Roche Anti-tumor Drug Product and Services
    Table 38. Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Roche Recent Developments/Updates
    Table 40. Roche Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Anti-tumor Drug Product and Services
    Table 44. Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Celgene Basic Information, Area Served and Competitors
    Table 48. Celgene Major Business
    Table 49. Celgene Anti-tumor Drug Product and Services
    Table 50. Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Celgene Recent Developments/Updates
    Table 52. Celgene Competitive Strengths & Weaknesses
    Table 53. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 54. Bristol-Myers Squibb Major Business
    Table 55. Bristol-Myers Squibb Anti-tumor Drug Product and Services
    Table 56. Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Bristol-Myers Squibb Recent Developments/Updates
    Table 58. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 59. Amgen Basic Information, Area Served and Competitors
    Table 60. Amgen Major Business
    Table 61. Amgen Anti-tumor Drug Product and Services
    Table 62. Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Amgen Recent Developments/Updates
    Table 64. Amgen Competitive Strengths & Weaknesses
    Table 65. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 66. Johnson & Johnson Major Business
    Table 67. Johnson & Johnson Anti-tumor Drug Product and Services
    Table 68. Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Johnson & Johnson Recent Developments/Updates
    Table 70. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 71. Pfizer Basic Information, Area Served and Competitors
    Table 72. Pfizer Major Business
    Table 73. Pfizer Anti-tumor Drug Product and Services
    Table 74. Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Pfizer Recent Developments/Updates
    Table 76. Pfizer Competitive Strengths & Weaknesses
    Table 77. Takeda Basic Information, Area Served and Competitors
    Table 78. Takeda Major Business
    Table 79. Takeda Anti-tumor Drug Product and Services
    Table 80. Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Takeda Recent Developments/Updates
    Table 82. Takeda Competitive Strengths & Weaknesses
    Table 83. Eli Lilly Basic Information, Area Served and Competitors
    Table 84. Eli Lilly Major Business
    Table 85. Eli Lilly Anti-tumor Drug Product and Services
    Table 86. Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Eli Lilly Recent Developments/Updates
    Table 88. Eli Lilly Competitive Strengths & Weaknesses
    Table 89. AstraZeneca Basic Information, Area Served and Competitors
    Table 90. AstraZeneca Major Business
    Table 91. AstraZeneca Anti-tumor Drug Product and Services
    Table 92. AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. AstraZeneca Recent Developments/Updates
    Table 94. AstraZeneca Competitive Strengths & Weaknesses
    Table 95. Astellas Basic Information, Area Served and Competitors
    Table 96. Astellas Major Business
    Table 97. Astellas Anti-tumor Drug Product and Services
    Table 98. Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Astellas Recent Developments/Updates
    Table 100. Astellas Competitive Strengths & Weaknesses
    Table 101. Merck & Co Basic Information, Area Served and Competitors
    Table 102. Merck & Co Major Business
    Table 103. Merck & Co Anti-tumor Drug Product and Services
    Table 104. Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Merck & Co Recent Developments/Updates
    Table 106. Merck & Co Competitive Strengths & Weaknesses
    Table 107. Sanofi Basic Information, Area Served and Competitors
    Table 108. Sanofi Major Business
    Table 109. Sanofi Anti-tumor Drug Product and Services
    Table 110. Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Sanofi Recent Developments/Updates
    Table 112. Sanofi Competitive Strengths & Weaknesses
    Table 113. Bayer Basic Information, Area Served and Competitors
    Table 114. Bayer Major Business
    Table 115. Bayer Anti-tumor Drug Product and Services
    Table 116. Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Bayer Recent Developments/Updates
    Table 118. Bayer Competitive Strengths & Weaknesses
    Table 119. Biogen Idec Basic Information, Area Served and Competitors
    Table 120. Biogen Idec Major Business
    Table 121. Biogen Idec Anti-tumor Drug Product and Services
    Table 122. Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Biogen Idec Recent Developments/Updates
    Table 124. Biogen Idec Competitive Strengths & Weaknesses
    Table 125. Eisai Basic Information, Area Served and Competitors
    Table 126. Eisai Major Business
    Table 127. Eisai Anti-tumor Drug Product and Services
    Table 128. Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Eisai Recent Developments/Updates
    Table 130. Eisai Competitive Strengths & Weaknesses
    Table 131. Teva Basic Information, Area Served and Competitors
    Table 132. Teva Major Business
    Table 133. Teva Anti-tumor Drug Product and Services
    Table 134. Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Teva Recent Developments/Updates
    Table 136. Otsuka Basic Information, Area Served and Competitors
    Table 137. Otsuka Major Business
    Table 138. Otsuka Anti-tumor Drug Product and Services
    Table 139. Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 140. Global Key Players of Anti-tumor Drug Upstream (Raw Materials)
    Table 141. Anti-tumor Drug Typical Customers
List of Figure
    Figure 1. Anti-tumor Drug Picture
    Figure 2. World Anti-tumor Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Anti-tumor Drug Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Anti-tumor Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Anti-tumor Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Anti-tumor Drug Revenue (2019-2030) & (USD Million)
    Figure 13. Anti-tumor Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Anti-tumor Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Anti-tumor Drug by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Anti-tumor Drug Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Anti-tumor Drug Markets in 2023
    Figure 27. United States VS China: Anti-tumor Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Anti-tumor Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Anti-tumor Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Anti-tumor Drug Market Size Market Share by Type in 2023
    Figure 31. Cytotoxic Drugs
    Figure 32. Non-cytotoxic Drugs
    Figure 33. World Anti-tumor Drug Market Size Market Share by Type (2019-2030)
    Figure 34. World Anti-tumor Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Anti-tumor Drug Market Size Market Share by Application in 2023
    Figure 36. Alkylating Agents
    Figure 37. Anti-Metabolism Drugs
    Figure 38. Platinum Antineoplastic Agents
    Figure 39. Anthracycline Antitumor Drugs
    Figure 40. Microtubule Stabilizer
    Figure 41. Endocrine Therapy Drugs
    Figure 42. Immunotherapy Drugs
    Figure 43. Gene Therapy Drugs
    Figure 44. Targeted Antineoplastic Drugs
    Figure 45. Anti-tumor Drug Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Companies Mentioned

Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka